Targeted immuno-antiretroviral HIV therapeutic approach to provide dual protection and boosts cellular immunity: A proof-of-concept study
S. Mandal, S. W. Sunagawa, P. K. Prathipati, M. Belshan, A. Shibata, C. J. Destache
This study develops a dual-action nanoformulation combining a CCR5 monoclonal antibody and antiretrovirals to enhance HIV protection and immune response, showing improved efficacy compared to individual components.
bioRxiv · Apr 20, 2020 · PreprintImmunology